Eupraxia Pharmaceuticals Inc.EPRX
Price (close)
$8.01
Market cap
$529.2M
P/E
—
Revenue (FY)
$0
Net income
-$38.6M
Dividend yield
—
1-year total return
39.1%
Net margin
—
Revenue growth
—
Debt / equity
—
What Eupraxia Pharmaceuticals Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $0 |
| Net income | — | -$18.5M | -$28.2M | -$25.5M | -$38.6M |
More on EPRX.
- Eupraxia Pharmaceuticals Inc. summary
- Eupraxia Pharmaceuticals Inc. financial statements
- Eupraxia Pharmaceuticals Inc. key metrics
- Eupraxia Pharmaceuticals Inc. health scores and style box
- Eupraxia Pharmaceuticals Inc. earnings
- Eupraxia Pharmaceuticals Inc. dividends
- Eupraxia Pharmaceuticals Inc. valuation
- Eupraxia Pharmaceuticals Inc. ownership and insiders
- Eupraxia Pharmaceuticals Inc. peers
Figures from Eupraxia Pharmaceuticals Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.